Ligand Pharmaceuticals (NASDAQ:LGND): Q1 Non-GAAP EPS of $0.89 beats by $0.23; GAAP EPS of -$1.46 misses by $1.58.
Revenue of $33.16M (-23.7% Y/Y) beats by $6.46M.
https://seekingalpha.com/news/3570385-ligand-pharmaceuticals-eps-beats-0_23-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.